An update on the dietary ligands of the AhR

Expert Opinion on Drug Metabolism and Toxicology

Volumn 4, Issue 11, 2008, Pages 1429-1447

  Ashida, Hitoshi ^a   Nishiumi, Shin ^a   Fukuda, Itsuko ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

AhR; Carotenoid; Curcumin; CYP1A1; Drug metabolizing enzymes; Flavonoid; Indigoid; TCDD

Indexed keywords

ALDEHYDE DEHYDROGENASE; AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BREAST CANCER RESISTANCE PROTEIN; CURCUMIN; CYTOCHROME P450; DIOXIN; DNA; DRUG METABOLIZING ENZYME; EPIGALLOCATECHIN GALLATE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A6; GLUTATHIONE TRANSFERASE; HALOGENATED HYDROCARBON; HEAT SHOCK PROTEIN 90; HYPOXIA INDUCIBLE FACTOR 1BETA; INDIRUBIN; ISOFLAVONE DERIVATIVE; MULTIDRUG RESISTANCE PROTEIN; ORGANIC ANION TRANSPORTER; POLYCYCLIC AROMATIC HYDROCARBON; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); THEAFLAVIN; UNINDEXED DRUG; XANTHOPHYLL; ZEAXANTHIN;

ANTIOXIDANT ACTIVITY; DIMERIZATION; DNA BINDING; DRUG STRUCTURE; ENVIRONMENTAL EXPOSURE; FOOD CONTAMINATION; FOOD INTAKE; HUMAN; HYDROPHOBICITY; MOLECULAR MECHANICS; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEAR LOCALIZATION SIGNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; TOXICOKINETICS;

ANIMALS; CAROTENOIDS; CURCUMIN; DIET; ENZYMES; FLAVONOIDS; FOOD ANALYSIS; HUMANS; PHARMACEUTICAL PREPARATIONS; RECEPTORS, ARYL HYDROCARBON;

EID: 56749128218     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425255.4.11.1429     Document Type: Review

References (182)

1. Kawajiri K, Fujii-Kuriyama Y. Cytochrome P450 gene regulation and physiological functions mediated by the aryl hydrocarbon receptor. Arch Biochem Biophys 2007;464:207-12
2. Hankinson O. The aryl hydrocarbon receptor complex. Ann Rev Pharmacol Toxicol 1995;35:307-40
3. Schmidt JV, Bradfield CA. Ah receptor signaling pathways. Ann Rev Cell Dev Biol 1996;12:55-89
4. Ma Q, Whitlock JP Jr. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol Cell Biol 1996;16:2144-50
5. Puga A, Marlowe J, Barnes S, et al. Role of the aryl hydrocarbon receptor in cell cycle regulation. Toxicology 2002;181-182:171-7
6. Bock KW, Kohle C. Ah receptor- and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis. Biochem Pharmacol 2005;69:1403-8
7. Huang G, Elferink CJ. Multiple mechanisms are involved in Ah receptor-mediated cell cycle arrest. Mol Pharmacol 2005;67:88-96
8. Nguyen LP, Bradfield CA. The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 2008;21:102-16
9. Denison MS, Pandini A, Nagy SR, et al. Ligand binding and activation of the Ah receptor. Chem Biol Interact 2002;141:3-24
10. Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Ann Rev Pharmacol Toxicol 2003;43:309-34
11. Mandal PK. Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J Comp Physiol [B] 2005;175:221-30
12. Bock KW, Kohle C. Coordinate regulation of drug metabolism by xenobiotic nuclear receptors: UGTs acting together with CYPs and glucuronide transporters. Drug Metab Rev 2004;36:595-615
13. Kohle C, Bock KW. Coordinate regulation of phase I and II xenobiotic metabolisms by the Ali receptor and Nrf2. Biochem Pharmacol 2007;73:1853-62
14. Hankinson O. Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Arch Biochem Biophys 2005;433:379-86
15. Canivenc-Lavier MC, Vernevaut MF, Totis M, et al. Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver. Toxicology 1996;114:19-27
16. Ciolino HP, Daschner PJ, Wang TTY, Yeh GC. Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem Pharmacol 1998;56:197-206
17. Ciolino HP, Daschner PJ, Yeh GC. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem J 1999;340(Pt 3):715-22
18. Ciolino HP, Wang TT, Yeh GC. Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer Res 1998;58:2754-60
19. Ashida H, Fukuda I, Yamashita T, Kanazawa K. Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin. FEBS Lett 2000;476:213-7
20. Adachi J, Mori Y, Matsui S, et al. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem 2001;276:31475-8
21. Mimura J, Fujii-Kuriyama Y. Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta 2003;1619:263-8
22. Pocar P, Fischer B, Klonisch T, Hombach-Klonisch S. Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction. Reproduction 2005;129:379-89
23. Kewley RJ, Whitelaw ML, Chapman-Smith A. The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int J Biochem Cell Biol 2004;36:189-204
24. Ramadoss P, Perdew GH. The transactivation domain of the Ah receptor is a key determinant of cellular localization and ligand-independent nucleocytoplasmic shuttling properties. Biochemistry 2005;44:11148-59
25. Chen HS, Perdew GH. Subunit composition of the heteromeric cytosolic aryl hydrocarbon receptor complex. J Biol Chem 1994;269:27554-8
26. Meyer BK, Pray-Grant MG, Vanden Heuvel JP, Perdew GH. Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity. Mol Cell Biol 1998;18:978-88
27. Shetty PV, Bhagwat BY, Chan WK. P23 enhances the formation of the aryl hydrocarbon receptor-DNA complex. Biochem Pharmacol 2003;65:941-8
28. Pongratz I, Mason GG, Poellinger L. Dual roles of the 90-kDa heat shock protein hsp90 in modulating functional activities of the dioxin receptor. Evidence that the dioxin receptor functionally belongs to a subclass of nuclear receptors which require hsp90 both for ligand binding activity and repression of intrinsic DNA binding activity. J Biol Chem 1992;267:13728-34
29. Ma Q, Whitlock JP Jr. A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem 1997;272:8878-84
30. Meyer BK, Perdew GH. Characterization of the AhR-hsp90-XAP2 core complex and the role of the immunophilin-related protein XAP2 in AhR stabilization. Biochemistry 1999;38:8907-17
31. Kazlauskas A, Poellinger L, Pongratz I. The immunophilin-like protein XAP2 regulates ubiquitination and subcellular localization of the dioxin receptor. J Biol Chem 2000;275:41317-24
32. Kazlauskas A, Poellinger L, Pongratz, I. Evidence that the co-chaperone p23 regulates ligand responsiveness of the dioxin (Aryl hydrocarbon) receptor. J Biol Chem 1999;274:13519-24
33. Ikuta T, Eguchi H, Tachibana T, et al. Nuclear localization and export signals of the human aryl hydrocarbon receptor. J Biol Chem 1998;273:2895-904
34. Denison MS, Fisher JM, Whitlock JP Jr. Inducible, receptor-dependent protein-DNA interactions at a dioxin-responsive transcriptional enhancer. Proc Natl Acad Sci USA 1988;85:2528-32
35. Whitlock JP Jr. Mechanistic aspects of dioxin action. Chem Res Toxicol 1993;6:745-53
36. Probst MR, Reisz-Porszasz S, Agbunag RV, et al. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action. Mol Pharmacol 1993;44:511-8
37. Mimura J, Ema M, Sogawa K, Fujii-Kuriyama Y. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev 1999;13:20-5
38. Haarmann-Stemmann T, Abel J. The arylhydrocarbon receptor repressor (AhRR): structure, expression, and function. Biol Chem 2006;387:1195-9
39. Pongratz I, Stromstedt PE, Mason GG, Poellinger L. Inhibition of the specific DNA binding activity of the dioxin receptor by phosphatase treatment. J Biol Chem 1991;266:16813-7
40. Gradin K, Whitelaw ML, Toftgard R, et al. A tyrosine kinase-dependent pathway regulates ligand-dependent activation of the dioxin receptor in human keratinocytes. J Biol Chem 1994;269:23800-7
41. Li SY, Dougherty JJ. Inhibitors of serine/threonine-specific protein phosphatases stimulate transcription by the Ah receptor/Arnt dimer by affecting a step subsequent to XRE binding. Arch Biochem Biophys 1997;340:73-82
42. Chen YH, Tukey RH. Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J Biol Chem 1996;271:26261-6
43. Long WP, Pray-Grant M, Tsai JC, Perdew GH. Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. Mol Pharmacol 1998;53:691-700
44. Poland A, Knutson JC. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Ann Rev Pharmacol Toxicol 1982;22:517-54
45. Van den Berg M, Birnbaum L, Bosveld AT, et al. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 1998;106:775-92
46. Sinal CJ, Bend JR. Aryl hydrocarbon receptor-dependent induction of cyp1a1 by bilirubin in mouse hepatoma hepa 1c1c7 cells. Mol Pharmacol 1997;52:590-9
47. Moorthy B. Persistent expression of 3-methylcholanthrene-inducible cytochromes P4501A in rat hepatic and extrahepatic tissues. J Pharmacol Exp Ther 2000;294:313-22
48. Saeki K, Matsuda T, Kato TA, et al. Activation of the human Ah receptor by aza-polycyclic aromatic hydrocarbons and their halogenated derivatives. Biol Pharm Bull 2003;26:448-52
49. Soprano DR, Gambone CJ, Sheikh SN, et al. The synthetic retinoid AGN 193109 but not retinoic acid elevates CYP1A1 levels in mouse embryos and Hepa-1c1c7 cells. Toxicol Appl Pharmacol 2001;174:153-9
50. Gambone CJ, Hutcheson JM, Gabriel JL, et al. Unique property of some synthetic retinoids: activation of the aryl hydrocarbon receptor pathway. Mol Pharmacol 2002;61:334-42
51. Backlund M, Ingelman-Sundberg M. Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation. Mol Pharmacol 2004;65:416-25
52. Murray IA, Perdew GH. Omeprazole stimulates the induction of human insulin-like growth factor binding protein-1 through aryl hydrocarbon receptor activation. J Pharmacol Exp Ther 2008;324:1102-10
53. Ashida H. Suppressive effects of flavonoids on dioxin toxicity. Biofactors 2000;12:201-6
54. Fukuda I, Mukai R, Kawase M, et al. Interaction between the aryl hydrocarbon receptor and its antagonists, flavonoids. Biochem Biophys Res Commun 2007;359:822-7
55. Nishiumi S, Yamamoto N, Kodoi R, et al. Antagonistic and agonistic effects of indigoids on the transformation of an aryl hydrocarbon receptor. Arch Biochem Biophys 2008;470:187-99
56. Nishiumi S, Yoshida K, Ashida H. Curcumin suppresses the transformation of an aryl hydrocarbon receptor through its phosphorylation. Arch Biochem Biophys 2007;466:267-73
57. Amakura Y, Tsutsumi T, Sasaki K, et al. Influence of food polyphenols on aryl hydrocarbon receptor-signaling pathway estimated by in vitro bioassay. Phytochemistry 2008: published online 14 September 2007, doi: 10.1016/j.phytochem.2007.07.022
58. Amakura Y, Tsutsumi T, Sasaki K, et al. Screening of the inhibitory effect of vegetable constituents on the aryl hydrocarbon receptor-mediated activity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biol Pharm Bull 2003;26:1754-60
59. Adachi J, Mori Y, Matsui S, Matsuda T. Comparison of gene expression patterns between 2,3,7,8-tetrachlorodibenzo-p-dioxin and a natural arylhydrocarbon receptor ligand, indirubin. Toxicol Sci 2004;80:161-9
60. Sugihara K, Kitamura S, Yamada T et al. Aryl hydrocarbon receptor-mediated induction of microsomal drug-metabolizing enzyme activity by indirubin and indigo. Biochem Biophys Res Commun 2004;318:571-8
61. Peter Guengerich F, Martin MV, McCormick WA, et al. Aryl hydrocarbon receptor response to indigoids in vitro and in vivo. Arch Biochem Biophys 2004;423:309-16
62. Schaldach CM, Riby J, Bjeldanes LF. Lipoxin A4: a new class of ligand for the Ah receptor. Biochemistry 1999;38:7594-600
63. Savouret JF, Antenos M, Quesne M, et al. 7-Ketocholesterol is an endogenous modulator for the arylhydrocarbon receptor. J Biol Chem 2001;276:3054-9
64. Chiaro, CR, Morales JL, Prabhu KS, Perdew GH. Leukotriene A4 metabolites are endogenous ligands for the Ah receptor. Biochemistry 2008;47:8445-55
65. Nebert DW, Gonzalez FJ. P450 genes: structure, evolution, and regulation. Ann Rev Biochem 1987;56:945-93
66. Zhang L, Savas U, Alexander DL, Jefcoate CR. Characterization of the mouse Cyp1B1 gene. Identification of an enhancer region that directs aryl hydrocarbon receptor-mediated constitutive and induced expression. J Biol Chem 1998;273:5174-83
67. Choudhary D, Jansson I, Schenkman JB, et al. Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch Biochem Biophys 2003;414:91-100
68. Kawajiri K, Watanabe J, Eguchi H, Hayashi S. Genetic polymorphisms of drug-metabolizing enzymes and lung cancer susceptibility. Pharmacogenetics 1995;5(Spec No):S70-3
69. Kondraganti SR, Fernandez-Salguero P, Gonzalez FJ, et al. Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo. Int J Cancer 2003;103:5-11
70. Talaska G, Ginsburg D, LaDow K, et al. Impact of Cyp1a2 or Ahr gene knockout in mice: implications for biomonitoring studies. Toxicol Lett 2006;162:246-9
71. Murray S, Odupitan AO, Murray BP, et al. Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline. Xenobiotica 2001;31:135-51
72. Endo K, Uno S, Seki T, et al. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene. Toxicol Appl Pharmacol 2008;230:135-43
73. Vasiliou V, Puga A, Nebert DW. Negative regulation of the murine cytosolic aldehyde dehydrogenase-3 (Aldh-3c) gene by functional CYP1A1 and CYP1A2 proteins. Biochem Biophys Res Commun 1992;187:413-9
74. Vasdiou V, Reuter SF, Williams S, et al. Mouse cytosolic class 3 aldehyde dehydrogenase (Aldh3a1): gene structure and regulation of constitutive and dioxin-inducible expression. Pharmacogenetics 1999;9:569-80
75. Yueh MF, Huang YH, Hiller A, et al. Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1. J Biol Chem 2003;278:15001-6
76. Erichsen TJ, Ehmer U, Kalthoff S, et al. Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene. Toxicol Appl Pharmacol 2008;230:252-60
77. Munzel PA, Bookjans G, Mehner G, et al. Tissue-specific 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible expression of human UDP-glucuronosyltransferase UGT1A6. Arch Biochem Biophys 1996;335:205-10
78. Munzel PA, Schmohl S, Buckler F, et al. Contribution of the Ah receptor to the phenolic antioxidant-mediated expression of human and rat UDP-glucuronosyltransferase UGT1A6 in Caco-2 and rat hepatoma 5L cells. Biochem Pharmacol 2003;66:841-7
79. Rushmore TH, Pickett CB. Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J Biol Chem 1990;265:14648-53
80. Jaiswal AK. Human NAD(P)H:quinone oxidoreductase (NQO1) gene structure and induction by dioxin. Biochemistry 1991;30:10647-53
81. Rushmore TH, Kong AN. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr Drug Metab 2002;3:481-90
82. Xu C, Li CY, Kong AN. Induction of phase 1, II and III drug metabolism/ transport by xenobiotics. Arch Pharm Res 2005;28:249-68
83. Inskeep PB, Koga N, Cmarik JL, Guengerich FP. Covalent binding of 1,2-dihaloalkanes to DNA and stability of the major DNA adduct, S-[2-(N7-guanyl) ethyl]glutathione. Cancer Res 1986;46:2839-44
84. Mathieu MC, Lapierre I, Brault K, Raymond M. Aromatic hydrocarbon receptor (AhR). AhR nuclear translocator- and p53-mediated induction of the murine multidrug resistance mdr1 gene by 3-methylcholanthrene and benzo(a)pyrene in hepatoma. cells. J Biol Chem 2001;276:4819-27
85. Maher JM, Cheng X, Slitt AL, et al. Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metab Dispos 2005;33:956-62
86. Ebert B, Seidel A, Lampert A. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 2005;26:1754-63
87. Cheng Y, Maher J, Dieter MZ, Klaassen CD. Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways. Drug Metab Dispos 2005;33:1276-82
88. Jigorel E, Le Vee M, Boursier-Neyret C, et al. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos 2006;34:1756-63
89. Jos A, Segner H, Herradon B, et al. Induction of EROD activity by 1-phenylimidazole and beta-naphthoflavone in rainbow trout cultured hepatocytes: a comparative study. Toxicol In Vitro 2007;21:1307-10
90. Lee JE, Safe S. 3′, 4′-dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells. Toxicol Sci 2000;58:235-42
91. Guo M, Joiakim A, Reiners JJ Jr. Suppression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated aryl hydrocarbon receptor transformation and CYP1A1 induction by the phosphatidylinositol 3-kinase inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Biochem Pharmacol 2000;60:635-42
92. Reiners JJ Jr, Lee JY, Clift RE, et al. PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase. Mol Pharmacol 1998;53:438-45
93. Henry EC, Kende AS, Rucci G, et al. Flavone antagonists bind competitively with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) to the aryl hydrocarbon receptor but inhibit nuclear uptake and transformation. Mol Pharmacol 1999;55:716-25
94. Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000;130:S2073-85
95. Nijveldt RJ, van Nood E, van Hoorn DE, et al. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001;74:418-25
96. Middleton E Jr. Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol 1998;439:175-82
97. Yoshida H, Ishikawa T, Hosoai H, et al. Inhibitory effect of tea flavonoids on the ability of cells to oxidize low density lipoprotein. Biochem Pharmacol 1999;58:1695-703
98. Hong J, Smith TJ, Ho CT, et al. Effeccs of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem Pharmacol 2001;62:1175-83
99. Hope WC, Welton AF, Fiedler-Nagy C, et al. In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin. Biochem Pharmacol 1983;32:367-71
100. Paganga G, Rice-Evans CA. The identification of flavonoids as glycosides in human plasma. FEBS Lett 1997;401:78-82
101. Nakagawa K, Okuda S, Miyazawa T. Dose-dependent incorporation of tea carechins, (-)-epigallocatechin-3-gailate and (-)-epigallocatechin, into human plasma. Biosci Biotechnol Biochem 1997;61:1981-5
102. Cao G, Muccitelli HU, Sanchez-Moreno C, Prior RL. Anthocyanins are absorbed in glycated forms in elderly women: a pharmacokinetic study. Am J Clin Nutr 2001;73:920-6
103. Mulder TP, van Platerink CJ, Wijnand Schuyl PJ, van Amelsvoort JM. Analysis of theaflavins in biological fluids using liquid chromatograpby-electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl 2001;760:271-9
104. Zhang S, Qin C, Safe SH. Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. Environ Health Perspect 2003;111:1877-82
105. Ciolino HP, Yeh GC. The flavonoids galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor. Br J Cancer 1999;79:1340-6
106. Mukai R, Fukuda I, Hosokawa K, et al. Anthocyans fail to suppress transformation of aryl hydrocarbon receptor induced by dioxin. Biosci Biotechnol Biochem 2005;69:896-903
107. Palermo CM, Westlake CA, Gasiewicz TA. Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. Biochemistry 2005;44:5041-52
108. Fukuda I, Sakane I, Yabushita Y, et al. Pigments in green tea leaves (Camellia sinensis) suppress transformation of the aryl hydrocarbon receptor induced by dioxin. J Agric Food Chem 2004;52:2499-506
109. Fukuda I, Sakane I, Yabushita Y, et al. Black tea theaflavins suppres dioxin-induced transformation of the aryl hydrocarbon receptor. Biosci Biotechnol Biochem 2005;69:883-90
110. Rinaldi AL, Morse MA, Fields HW, et al. Curcumin activates the aryl hydrocarbon receptor yet significantly inhibits (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol bioactivation in oral squamous cell carcinoma cells and oral mucosa. Cancer Res 2002;62:5451-6
111. Garg R, Gupta S, Maru G. Dietary curcumin modulates transcriptional regulator(s) of phase I and phase II enzymes in benzo(a)pyrene-treated mice: mechanism of its anti-initiating action. Carcinogenesis 2008;29:1022-32
112. Spink BC, Hussain MM, Katz BH, et al. Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin. Biochem Pharmacol 2003;66:2313-21
113. Hoessel R, Leclerc S, Endicott JA, et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol 1999;1:60-7
114. Vogel CF, Li W, Sciullo E, et al. Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression. Am J Pathol 2007;171:1538-48
115. Hayashibara T, Yamada Y, Mori N, et al. Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ATL) leukemogenesis: constitutive activation of AhR in ATL. Biochem Biophys Res Commun 2003;300:128-34
116. Gillam EM, Aguinaldo AM, Notley LM, et al. Formation of indigo by recombinant mammalian cytochrome P450. Biochem Biophys Res Commun 1999;265:469-72
117. Gillam EM, Notley LM, Cai H, et al. Oxidation of indole by cytochrome P450 enzymes. Biochemistry 2000;39:13817-24
118. Blanz J, Ehninger G, Zeller KP. The isolation and identification of indigo and indirubin from urine of a patient with leukemia. Res Commun Chem Pathol Pharmacol 1989;64:145-56
119. Jackson AH, Jenkins RT, Grinstein M, et al. The isolation and identification of indigoid pigments from urine. Clin Chim Acta 1988;172:245-52
120. Harun NS, Nainar SK, Chong VH. Purple urine bag syndrome: a rare and interesting phenomenon. South Med J 2007;100:1048-50
121. Astorg P, Gradelet S, Leclerc J, et al. Effects of beta-carotene and canthaxanthin on liver xenobiotic-metabolizing enzymes in the rat. Food Chem Toxicol 1994;32:735-42
122. Astorg P, Gradelet S, Leclerc J, Siess MH. Effects of provitamin A or non-provitamin A carotenoids on liver xenobiotic-metabolizing enzymes in mice. Nutr Cancer 1997;27:245-9
123. Gradelet S, Astorg P, Leclerc J, et al. Effects of canthaxanthin, astaxanthin, lycopene and lutein on liver xenobiotic-metabolizing enzymes in the rat. Xenobiotica 1996;26:49-63
124. Gradelet S, Leclerc J, Siess MH, Astorg PO. beta-Apo-8′-carotenal, but not beta-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica 1996;26:909-19
125. Jewell C, O'Brien NM. Effect of dietary supplementation with carotenoids on xenobiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat. Br J Nutr 1999;81:235-42
126. Nishiumi S, Yabushita Y, Fukuda I, et al. Molokhia (Corchorus olitorius L.) extract suppresses transformation of the aryl hydrocarbon receptor induced by dioxins. Food Chem Toxicol 2006;44:250-60
127. Fierce Y, de Morais Vieira M, Piantedosi R, et al. In vitro and in vivo characterization of retinoid synthesis from beta-carotene. Arch Biochem Biophys 2008;472:126-38
128. Yang YM, Huang DY, Liu GF, et al. Inhibitory effects of vitamin A on TCDD-induced cytochrome P-450 1A1 enzyme activity and expression. Toxicol Sci 2005;85:727-34
129. Fallone F, Villard PH, Seree E, et al. Retinoids repress Ah receptor CYP1A1 induction pathway through the SMRT corepressor. Biochem Biophys Res Commun 2004;322:551-6
130. Inouye K, Mae T, Kondo S, Ohkawa H. Inhibitory effects of vitamin A and vitamin K on rat cytochrome P4501A1-dependent monooxygenase activity. Biochem Biophys Res Commun 1999;262:565-9
131. Kronenberg S, Esser C, Carlberg C. An aryl hydrocarbon receptor conformation acts as the functional core of nuclear dioxin signaling. Nucleic Acids Res 2000;28:2286-91
132. Weston WM, Nugent P, Greene RM. Inhibition of retinoic-acid-induced gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem Biophys Res Commun 1995;207:690-4
133. Wanner R, Panteleyev A, Henz BM, Rosenbach T. Retinoic acid affects the expression rate of the differentiation-related genes aryl hydrocarbon receptor, ARNT and keratin 4 in proliferative keratinocytes only. Biochim Biophys Acta 1996;1317:105-11
134. Lorick KL, Toscano DL, Toscano WA Jr. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters retinoic acid receptor function in human keratinocytes. Biochem Biophys Res Commun 1998;243:749-52
135. Ashida H, Matsumura F. Effect of in vivo administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on DNA-binding activities of nuclear transcription factors in liver of guinea pigs. J Biochem Mol Toxicol 1998;12:191-204
136. Nguyen TA, Hoivik D, Lee JE, Safe S. Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. Arch Biochem Biophys 1999;367:250-7
137. Widerak M, Ghoneim C, Dumontier MF, et al. The aryl hydrocarbon receptor activates the retinoic: acid receptoralpha through SMRT antagonism. Biochimie 2006;88:387-97
138. Vecchini F, Lenoir-Viale MC, Cathelineau C, et al. Presence of a retinoid responsive element in the promoter region of the human cytochrome P4501A1 gene. Biochem Biophys Res Commun 1994;201:1205-12
139. Andreola F, Fernandez-Salguero PM, Chiantore MV, et al. Aryl hydrocarbon receptor knockout mice (AHR-/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Res 1997;57:2835-8
140. Zaher H, Fernandez-Salguero PM, Letterio J, et al. The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta an apoptosis. Mol Pharmacol 1998;54:313-21
141. Andreola F, Hayhurst GP, Luo G, et al. Mouse liver CYP2C39 is a novel retinoic acid 4-hydroxylase. Its down-regulation offers a molecular basis for liver retinoid accumulation and fibrosis in aryl hydrocarbon receptor-null mice. J Biol Chem 2004;279:3434-8
142. Wanner R, Brommer S, Czarnetzki BM, Rosenbach T. The differentiation-related upregulation of aryl hydrocarbon receptor transcript levels is suppressed by retinoic acid. Biochem Biophys Res Commun 1995;209:706-11
143. Hayashida Y, Kawamura T, Hori-e R, Yamashita I. Retionic acid and its receptors are required for expression of aryl hydrocarbon receptor mRNA and embryonic development of blood vessel and bone in the medaka fish, Oryzias latipes. Zoolog Sci 2004;21:541-51
144. Ciolino HP, Yeh GC. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 1999;56:760-7
145. Wanzel E, Somoza V. Metaboism and bioavailability of trans-resveratrol. Mol Nutr Food Res 2005;49:472-81
146. Espin JC, Garcia-Conesa MT, Tomas-Barberan FA. Nutraceuticals: Facts and fiction. Phytochemistry 2007;68:2986-3008
147. Walle T, Hsieh F, DeLegge MH, et al. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004;32:1377-82
148. Morita K, Ogata M, Hasegawa T. Chlorophyll derived from Chlorella inhibits dioxin absorption from the gastrointestinal tract and accelerates dioxin excretion in rats. Environ Health Perspect 2001;109:289-94
149. Natsume Y, Satsu H, Hatsugi Y, et al. Evaluation of intestinal dioxin permeability using human Caco-2 cell monolayers. Food Sci Technol Res 2003;9:364-6
150. Phelan D, Winter GM, Rogers WJ, et al. Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch Biochem Biophys 1998;357:155-63
151. Ferruzzi MG, Failla ML, Schwartz SJ. Assessment of degradation and intestinal cell uptake of carotenoids and chlorophyll derivatives from spinach puree using an in vitro digestion and Caco-2 human cell model. J Agric Food Chem 2001;49:2082-9
152. Morita K, Matsueda T, Iida T, Hasegawa T. Chlorella accelerates dioxin excretion in rats. J Nutr 1999;129:1731-6
153. Hashimoto T, Nonaka Y, Minato K-I, et al. Suppressive effect of polysaccharides from edible and medicinal mushrooms, Lentinus edodes and Agaricus blazei, on the expression of cytochrome P450s in mice. Biosci Biotechnol Biochem 2002;66:1610-4
154. Kanazawa K, Yamashita T, Ashida H, Danno G. Antimutagenicity of flavones and flavonols to heterocyclic amines by specific and strong inhibition of the cytochrome P450 1A family. Biosci Biotechnol Biochem 1998;62:970-7
155. Morgan ET. Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo Independence from the hypothalamo-pituitary axis. Biochem Pharmacol 1993;45:415-9
156. Tian Y, Ke S, Denison MS, et al. Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J Biol Chem 1999;274:510-5
157. Matsumura F, Vogel CF. Evidence supporting the hypothesis that one of the main functions of the aryl hydrocarbon receptor is mediation of cell stress responses. Biol Chem 2006;387:1189-94
158. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Ann Rev Nutr 2002;22:19-34
159. Dias AS, Porawski M, Alonso M, et al. Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J Nutr 2005;135:2299-304
160. Moon YJ, Wang X, Morris ME. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 2006;20:187-210
161. Ermakova SP, Kang BS, Choi BY, et al. (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res 2006;66:9260-9
162. Murakami A, Ashida H, Terao J. Multitargeted cancer prevention by quercetin. Cancer Lett 2008;269:315-25
163. Talalay P. Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors 2000;12:5-11
164. Surh YJ, Kundu JK, Na HK, Lee JS. Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals. J Nutr 2005;135:2993S-3001S
165. Na HK, Surh YJ. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food Chem Toxicol 2008;46:1271-8
166. Jeong WS, Jun M, Kong AN. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal 2006;8:99-106
167. Saracino MR, Lampe JW. Phytochemical regulation of UDP-glucuronosyltransferases: implications for cancer prevention. Nutr Cancer 2007;59:121-41
168. Anuchapreeda S, Leechanachai P, Smith MM, et al. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 2002;64:573-82
169. Nabekura T, Kamiyama S, Kitagawa S. Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem Biophys Res Commun 2005;327:866-70
170. O'Leary KA, Day AJ, Needs PW, et al. Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 2003;65:479-91
171. Murota K, Terao J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys 2003;417:12-7
172. Murota K, Terao J. Quercetin appears in the lymph of unanesthetized rats as its phase II metabolites after administered into the stomach. FEBS Lett 2005;579:5343-6
173. Hamada M, Satsu H, Natsume Y, et al. TCDD-induced CYP1A1 expression, an index of dioxin toxicity, is suppressed by flavonoids permeating the human intestinal Caco-2 cell monolayers. J Agric Food Chem 2006;54:8891-8
174. Unlu NZ, Bohn T, Francis D, et al. Carotenoid absorption in humans consuming tomato sauces obtained from tangerine or high-beta-carotene varieties of tomatoes. J Agric Food Chem 2007;55:1597-603
175. Lin JK. Suppression of protein kinase C and nuclear oncogene expression as possible action mechanisms of cancer chemoprevention by Curcumin. Arch Pharm Res 2004;27:683-92
176. Rannug U, Rannug A, Sjoberg U, et al. Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem Biol 1995;2:841-5
177. Rannug A, Rannug U, Rosenkranz HS, et al. Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances. J Biol Chem 1987;262:15422-7
178. Kato R. Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates. Crit Rev Toxicol 1986;16:307-48
179. Koide A, Fuwa K, Furukawa F, et al. Effect of cigarette smoke on the mutagenic activation of environmental carcinogens by rodent liver. Mutat Res 1999;428:165-76
180. Garrison PM, Tullis K, Aarts JM, et al. Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. Fundam Appl Toxicol 1996;30:194-203
181. Ema M, Ohe N, Suzuki M, et al. Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors. J Biol Chem 1994;269:27337-43
182. Sanderson JT, Bellward GD. Hepatic microsomal ethoxyresorufin O-deethylase-inducing potency in ovo and cytosolic Ah receptor binding affinity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: comparison of four avian species. Toxicol Appl Pharmacol 1995;132:131-45